APA (7th ed.) Citation

Yamanaka, T., Yoshida, H., Shimoi, T., Sudo, K., & Yonemori, K. (2026). Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection. Current Oncology, 31(2), 124. https://doi.org/10.3390/curroncol33020124

Chicago Style (17th ed.) Citation

Yamanaka, Taro, Hiroshi Yoshida, Tatsunori Shimoi, Kazuki Sudo, and Kan Yonemori. "Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection." Current Oncology 31, no. 2 (2026): 124. https://doi.org/10.3390/curroncol33020124.

MLA (9th ed.) Citation

Yamanaka, Taro, et al. "Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection." Current Oncology, vol. 31, no. 2, 2026, p. 124, https://doi.org/10.3390/curroncol33020124.